We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

By LabMedica International staff writers
Posted on 29 Apr 2024

The COVID pandemic has dramatically reshaped the perception of diagnostics. More...

Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable unit could revolutionize the way samples are collected for diagnostic tests.

ReadyGo Diagnostics’ (Bath, UK) Sampler device incorporates both the swab and collection buffers into one device, making it exceptionally user-friendly. It is the world’s first universal tool of its kind that ensures convenience, reliability, and reproducibility right from the initial step of a diagnostic test. The patented technology behind the ReadyGo Sampler uses specially engineered materials that not only allow the device to collect the exact amount of sample required instantly but also rapidly break open viruses and bacteria, making them readily detectable in specific tests. The ReadyGo Sampler device is intended to be a more user-oriented alternative to conventional swab-based sample collection methods by combining sample collection and processing into one disposable product.

This device is versatile, and compatible with various types of assays and uses, facilitating a swift and simple collection process that takes as little as five seconds. The Sampler is designed to cater to both consumer and professional testing markets and can accommodate various sample types such as saliva, buccal, blood, and urine. The patented Sampler device works with molecular tests like PCR and isothermal chemistries such as LAMP and RPA. Additionally, it is suitable for use in front of next-generation sequencing (NGS) protocols, including targeted sequencing and whole genome amplification (WGA). The technology allows for easy adaptation to incorporate other test chemistries, broadening its application to include simplified methods for biochemistry testing of physiological markers related to health and disease.

Related Links:
ReadyGo Diagnostics


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Automated Clinical Chemistry Analyzer
Envoy 500+
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings point to readily accessible blood biomarkers that could support disability risk stratification in geriatric care (Image Credit: Adobe Stock)

Blood Test Markers Could Help Identify Older Adults at Risk of Disability

Maintaining independence into very old age is a growing public health challenge as Japan’s population rapidly ages. Nearly 60% of Japanese adults aged 85 years and older already receive support through... Read more

Industry

view channel
Image Credit: Shutterstock

New Collaboration Advances Precision Oncology Screening for Lung Cancer in Japan

Molecular profiling is central to precision oncology in lung cancer, but tissue samples can be limited and minimally invasive approaches are often preferable. Liquid biopsy enables blood-based genomic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.